PRICE T ROWE ASSOCIATES INC /MD/ - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$128,000
-28.1%
26,000
-22.8%
0.00%
Q2 2021$178,000
-41.8%
33,700
-47.1%
0.00%
Q1 2021$306,000
+10.9%
63,7000.0%0.00%
Q4 2020$276,000
+5.3%
63,7000.0%0.00%
Q3 2020$262,000
+21.3%
63,700
-24.4%
0.00%
Q2 2020$216,000
-12.9%
84,300
-1.7%
0.00%
Q1 2020$248,000
-5.0%
85,739
+24.4%
0.00%
Q4 2019$261,000
-13.3%
68,939
+17.0%
0.00%
Q3 2019$301,000
-17.5%
58,928
+0.2%
0.00%
Q2 2019$365,000
+305.6%
58,797
+366.8%
0.00%
Q1 2019$90,000
-15.9%
12,597
+0.8%
0.00%
Q4 2018$107,000
-68.0%
12,497
-25.0%
0.00%
Q3 2018$334,000
-21.8%
16,661
+0.8%
0.00%
Q2 2018$427,00016,5320.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders